Phase 3 Readout

HWH: Phase 3 Topline: An Open Label, Randomized Non-Inferiority Trial Comparing Safety and Immunogenicity of Intradermal V

Name: Phase 3 Topline: An Open Label, Randomized Non-Inferiority Trial Comparing Safety and Immunogenicity of Intradermal V
Start: 2027-07-15
End: 2027-07-15

July 15, 2027. BioSniper AI can trace the company-impact path without requiring you to write the research question.

Event date: July 15, 2027
Company: HWH International Inc. (HWH)

BioSniper AIPage evidence connected

Prepared research question

What could this event change, and which evidence should be watched next?

Run cited research

Traceable citations · Unknowns marked

Phase 3 Readout~month

Phase 3 Topline: An Open Label, Randomized Non-Inferiority Trial Comparing Safety and Immunogenicity of Intradermal V

July 15, 2027

HWH overview →

Company: HWH International Inc. (HWH)
Indication: Rabies